Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline.

Freeman EW, Rickels K, Sammel MD, Lin H, Sondheimer SJ.

Arch Gen Psychiatry. 2009 May;66(5):537-44. doi: 10.1001/archgenpsychiatry.2008.547.

2.

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S.

Am J Psychiatry. 2004 Feb;161(2):343-51.

PMID:
14754784
3.

Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.

Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M.

JAMA Psychiatry. 2015 Oct;72(10):1037-44. doi: 10.1001/jamapsychiatry.2015.1472.

4.

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.

Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):317-21.

PMID:
15780701
5.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
6.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
7.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
8.
9.

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.

Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W.

JAMA. 1997 Sep 24;278(12):983-8.

PMID:
9307345
10.

Predictors of response to sertraline treatment of severe premenstrual syndromes.

Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B.

J Clin Psychiatry. 2000 Aug;61(8):579-84.

PMID:
10982201
11.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
12.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
13.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Marjoribanks J, Brown J, O'Brien PM, Wyatt K.

Cochrane Database Syst Rev. 2013 Jun 7;(6):CD001396. doi: 10.1002/14651858.CD001396.pub3. Review.

PMID:
23744611
14.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
15.

Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, Leblanc GA.

J Clin Psychopharmacol. 2004 Oct;24(5):540-3.

PMID:
15349012
16.

Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.

Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ.

J Clin Psychopharmacol. 1999 Feb;19(1):3-8.

PMID:
9934936
17.

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S.

Obstet Gynecol. 2002 Sep;100(3):435-44.

PMID:
12220761
18.

Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD.

J Clin Psychiatry. 2008 Jun;69(6):991-8.

PMID:
18517289
19.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
20.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
Items per page

Supplemental Content

Support Center